Castle Creek Arbitrage’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History

Castle Creek Arbitrage’s Portfolio HWEL Stock Details HWEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-765,749	Closed	-$7.96M	–	221
2023 Q3	$7.96M	Sell	765,749 -1,629,235	-68%	-$16.8M	1.87%	13
2023 Q2	$24.6M	Hold	2,394,984	–	–	3.05%	5
2023 Q1	$24.3M	Hold	2,394,984	–	–	2.67%	5
2022 Q4	$23.7M	Hold	2,394,984	–	–	2.09%	5
2022 Q3	$23.3M	Buy	2,394,984 +44,984	+2%	+$437K	1.29%	5
2022 Q2	$22.7M	Hold	2,350,000	–	–	1.24%	8
2022 Q1	$22.7M	Sell	2,350,000 -50,000	-2%	-$482K	1.14%	9
2021 Q4	$23.3M	Buy	+2,400,000	New	+$23.3M	1.16%	9

Castle Creek Arbitrage's HWEL Position: Q4 2023 in Review

Castle Creek Arbitrage sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q4 2023, closing a stake of 765,749 shares — an estimated $7.96M sold.

Castle Creek Arbitrage first reported a position in HWEL in Q4 2021 and held it in 8 quarters. The position peaked at $24.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold HWEL as of Q4 2023.

Castle Creek Arbitrage reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q4 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 765,749 Healthwell Acquisition Corp. I Class A Common Stock shares in Q4 2023, an estimated $7.96M.
Castle Creek Arbitrage first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 8 quarters.
Castle Creek Arbitrage's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $24.6M in Q2 2023.
0 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q4 2023.

Based on Castle Creek Arbitrage's 13F filing for Q4 2023.